New mechanism of radioresistance formation shown in lung adenocarcinoma

by Zhang Nannan,Chinese Academy of SciencesGOLPH3 mediates radioresistance formation of lung adenocarcinoma. Credit: Kong PeizhongA research team led by Prof. Han Wei from the Hefei Institutes o

Updated on: December 22,2023

New mechanism of radioresistance formation shown in lung adenocarcinoma

by Zhang Nannan,Chinese Academy of SciencesGOLPH3 mediates radioresistance formation of lung adenocarcinoma. Credit: Kong PeizhongA research team led by Prof. Han Wei from the Hefei Institutes o

Updated on:December 22,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on: December 22,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on:December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on: December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on:December 22,2023

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on: July 17,2024

Entering the golden age for antibody-drug conjugates in gynecologic cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn an editorial, published inOncosciencetitled, "Entering the golden age for antibody-drug conjugates in gynecologic cancer,&quo

Updated on:July 17,2024

Bringing crucial cancer treatments to rural communities

by Velvet Hasner,Missouri University of Science and TechnologyCredit: Pexels image by Peter FazekasFresh air, sunsets, and a night sky full of stars are a few of the benefits to country living t

Updated on: December 26,2023

Bringing crucial cancer treatments to rural communities

by Velvet Hasner,Missouri University of Science and TechnologyCredit: Pexels image by Peter FazekasFresh air, sunsets, and a night sky full of stars are a few of the benefits to country living t

Updated on:December 26,2023

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

Updated on: December 26,2023

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

Updated on:December 26,2023

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

Updated on: July 09,2024

CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A: Study

by Higher Education PressCoactivator-associated arginine methyltransferase 1 (CARM1) was recruited by hypoxia-inducible factor 1 subunit alpha (HIF1A) to form a complex and transactivate CDK4 and HIF1

Updated on:July 09,2024

Development and application of competing risks and multi-state models in cancer epidemiology

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainCompeting risks and multi-state models allow us to study complex disease settings and answer composite research questions and should be u

Updated on: December 18,2023

Development and application of competing risks and multi-state models in cancer epidemiology

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainCompeting risks and multi-state models allow us to study complex disease settings and answer composite research questions and should be u

Updated on:December 18,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Breast-conserving treatment without surgery not supported at this time

by NRG OncologyResults from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radio

Updated on: December 22,2023

Breast-conserving treatment without surgery not supported at this time

by NRG OncologyResults from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radio

Updated on:December 22,2023

Most cancer patients want access to complementary therapies before treatment

by The Reis GroupCredit: Pixabay/CC0 Public DomainNearly two-thirds (62%) of people with cancer want to know about complementary therapies such as exercise, nutrition counseling, massage, and meditati

Updated on: December 20,2023

Most cancer patients want access to complementary therapies before treatment

by The Reis GroupCredit: Pixabay/CC0 Public DomainNearly two-thirds (62%) of people with cancer want to know about complementary therapies such as exercise, nutrition counseling, massage, and meditati

Updated on:December 20,2023

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on: January 08,2024

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on:January 08,2024